Publications

Publications, Books, Book Chapters and Reviews by Prof. Marcus Maurer, MD

Use: Start with an overview of all publications. Use tag links to list selected documents or to list an entire category, e.g. Original Work, Books, Book Chapters, Reviews. If you know what you are looking for, enter this term in the search field.

Urticaria: Current Opinions about Etiology, Diagnosis and Therapy

Filename 16. Zuberbier&Maurer, Urt. curr. opin. about etiol, Acta Derm Venereol.2007.pdf
Filesize 400 KB
Version r.016
Date added June 21, 2020
Downloaded 0 times
Category Reviews
Tags definition, pathogenesis, therapy, urticaria
Authors Zuberbier, T. and Maurer, M.
Citation Zuberbier, T. and Maurer, M.: Urticaria: Current opinions about etiology, diagnosis and therapy. Acta Derm. Venereol. 2007: 87; 196-205.
Corresponding authors Zuberbier, T.
DocNum R.16
DocType PDF
Edition; Page 87; 196-205
IF 1.93
Publisher Acta Derm. Venereol.
ReleaseDate 2007

In the last few decades an increasing understanding of the pathomechanisms involved in urticaria has highlighted the heterogeneity of different subtypes. According to the new European Academy of Allergology and Clinical Immunology/Global Allergy and Asthma European Network/European Dermatology Forum (EAACI/GA²LEN/ EDF) guidelines, urticaria subtypes can be grouped into spontaneous urticaria, which includes acute urticaria and chronic urticaria, the physical urticarias, and other urticaria disorders, including, for example, contact urticaria. Clarity of nomenclature is required not only to choose the correct measures in diagnosis and management, but also to compare data from different studies. Urticaria has a profound impact on quality of life and performance. Effective treatment is thus required in all cases where avoidance of eliciting factors is not feasible. For symptomatic relief, non-sedating H1-antihistamines are the first choice in most subtypes of urticaria; however, double-blind controlled studies have shown that the dosages required may exceed those recommended for other diseases, e.g. allergic rhinitis. The current guidelines therefore suggest increasing the dosage up to fourfold, whereas alternative treatments should be reserved as add-on therapy for unresponsive patients

(Last update: 08.2021)

Number of publications (original work and reviews) in peer-reviewed journals: 636
Number of original publications in peer-reviewed journals: 462
Number of reviews in peer-reviewed journals: 174
Cumulative IF of publications (original work & reviews) in peer-reviewed journals: 3834,12
Cumulative IF for original publications in peer-reviewed journals: 3043,14
Cumulative IF for reviews in peer-reviewed journals: 790,98
Citations, Hirsch index: (view on Web of Science) 26429